Update in Pulmonary Vascular Diseases and Right Ventricular Dysfunction 2019.
作者信息
Goncharova Elena A, Chan Stephen Y, Ventetuolo Corey E, Weissmann Norbert, Schermuly Ralph T, Mullin Christopher J, Gladwin Mark T
机构信息
Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute.
Division of Pulmonary, Allergy and Critical Care Medicine.
出版信息
Am J Respir Crit Care Med. 2020 Jul 1;202(1):22-28. doi: 10.1164/rccm.202003-0576UP.
Abstract
摘要
相似文献
1
Update in Pulmonary Vascular Diseases and Right Ventricular Dysfunction 2019.2019年肺血管疾病与右心室功能障碍的进展
Am J Respir Crit Care Med. 2020 Jul 1;202(1):22-28. doi: 10.1164/rccm.202003-0576UP.
2
Pulmonary arterial hypertension and right ventricular systolic dysfunction in COVID-19 survivors.新冠病毒疾病康复者的肺动脉高压和右心室收缩功能障碍
Cardiol J. 2022;29(1):163-165. doi: 10.5603/CJ.a2021.0159. Epub 2021 Dec 13.
3
Pulmonary Arterial Hypertension.肺动脉高压
N Engl J Med. 2021 Dec 16;385(25):2361-2376. doi: 10.1056/NEJMra2000348.
4
Right Ventricular Function After Pulmonary Artery Banding: Adaptive Processes Assessed by CMR and Conductance Catheter Measurements in Sheep.肺动脉环缩术后右心室功能：绵羊 CMＲ 和导丝测量评估的适应性过程。
J Cardiovasc Transl Res. 2019 Oct;12(5):459-466. doi: 10.1007/s12265-019-09881-6. Epub 2019 Mar 7.
5
The importance of right ventricular evaluation in risk assessment and therapeutic strategies: Raising the bar in pulmonary arterial hypertension.右心室评估在风险评估和治疗策略中的重要性：提高肺动脉高压的标准
Int J Cardiol. 2020 Feb 15;301:183-189. doi: 10.1016/j.ijcard.2019.10.043. Epub 2019 Nov 13.
6
[The patient with pulmonary embolism or vascular emergency requiring intensive care].患有肺栓塞或需要重症监护的血管急症的患者
Internist (Berl). 2010 Aug;51(8):995-8, 1000-2. doi: 10.1007/s00108-009-2541-5.
7
Right ventricular load and contractility in HIV-associated pulmonary hypertension.HIV相关性肺动脉高压中的右心室负荷与收缩功能
PLoS One. 2021 Feb 23;16(2):e0243274. doi: 10.1371/journal.pone.0243274. eCollection 2021.
8
Excitation-contraction coupling and relaxation alteration in right ventricular remodelling caused by pulmonary arterial hypertension.肺动脉高压导致右心室重构中的兴奋-收缩偶联和舒张改变。
Arch Cardiovasc Dis. 2020 Jan;113(1):70-84. doi: 10.1016/j.acvd.2019.10.009. Epub 2020 Jan 8.
9
Role of Long Non-Coding RNAs in Pulmonary Arterial Hypertension.长链非编码 RNA 在肺动脉高压中的作用。
Cells. 2021 Jul 26;10(8):1892. doi: 10.3390/cells10081892.
10
Risk Prediction and Right Ventricular Dilation in a Single-Institution Pulmonary Arterial Hypertension Cohort.单中心肺动脉高压队列中的风险预测与右心室扩张
J Am Heart Assoc. 2022 Jul 19;11(14):e025521. doi: 10.1161/JAHA.122.025521. Epub 2022 Jul 13.
引用本文的文献
1
Protein C Pretreatment Protects Endothelial Cells from SARS-CoV-2-Induced Activation.蛋白 C 预处理可保护血管内皮细胞免受 SARS-CoV-2 诱导的激活。
Viruses. 2024 Jun 28;16(7):1049. doi: 10.3390/v16071049.
2
miR-223: a key regulator of pulmonary inflammation.微小RNA-223：肺部炎症的关键调节因子
Front Med (Lausanne). 2023 Jul 3;10:1187557. doi: 10.3389/fmed.2023.1187557. eCollection 2023.
3
Mechanosensitive channel Piezo1 is required for pulmonary artery smooth muscle cell proliferation.机械敏感通道 Piezo1 对于肺动脉平滑肌细胞增殖是必需的。
Am J Physiol Lung Cell Mol Physiol. 2022 May 1;322(5):L737-L760. doi: 10.1152/ajplung.00447.2021. Epub 2022 Mar 23.
4
mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target.mTOR 信号通路在肺血管疾病中的作用：致病机制及治疗靶点。
Int J Mol Sci. 2021 Feb 21;22(4):2144. doi: 10.3390/ijms22042144.
本文引用的文献
1
BMP9/10 in Pulmonary Vascular Complications of Liver Disease.骨形态发生蛋白9/10与肝病的肺血管并发症
Am J Respir Crit Care Med. 2020 Jun 15;201(12):1575-1578. doi: 10.1164/rccm.201912-2514LE.
2
Risk Assessment and Monitoring of Chronic Pulmonary Hypertension in Premature Infants.早产儿慢性肺动脉高压的风险评估与监测
J Pediatr. 2020 Feb;217:199-209.e4. doi: 10.1016/j.jpeds.2019.10.034. Epub 2019 Nov 14.
3
Against the Odds: Risk Stratification with Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension.逆势而为：肺动脉高压中利用心脏磁共振成像进行风险分层
Am J Respir Crit Care Med. 2020 Feb 15;201(4):403-405. doi: 10.1164/rccm.201910-2069ED.
4
Characterization of Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension.肺动脉高压中 BMP9 和 BMP10 突变和水平的特征。
Am J Respir Crit Care Med. 2020 Mar 1;201(5):575-585. doi: 10.1164/rccm.201906-1141OC.
5
Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension.肺动脉高压危险分层的心脏磁共振成像阈值的确定。
Am J Respir Crit Care Med. 2020 Feb 15;201(4):458-468. doi: 10.1164/rccm.201909-1771OC.
6
Heart of the Matter? Early Ventricular Dysfunction in Congenital Diaphragmatic Hernia.问题的核心？先天性膈疝早期心室功能障碍
Am J Respir Crit Care Med. 2019 Dec 15;200(12):1462-1464. doi: 10.1164/rccm.201909-1737ED.
7
Retrospective Validation of the REVEAL 2.0 Risk Score With the Australian and New Zealand Pulmonary Hypertension Registry Cohort.REVEAL 2.0 风险评分的澳大利亚和新西兰肺动脉高压登记队列回顾性验证。
Chest. 2020 Jan;157(1):162-172. doi: 10.1016/j.chest.2019.08.2203. Epub 2019 Sep 26.
8
More Insights into the Association between RVX-208 and Pulmonary Arterial Hypertension.对RVX-208与肺动脉高压之间关联的更多见解。
Am J Respir Crit Care Med. 2020 Feb 1;201(3):388-389. doi: 10.1164/rccm.201908-1628LE.
9
Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension.免疫球蛋白驱动的补体激活调节肺动脉高压中的促炎重塑。
Am J Respir Crit Care Med. 2020 Jan 15;201(2):224-239. doi: 10.1164/rccm.201903-0591OC.
10
Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension.超越肺部：肺动脉高压的系统性表现。
Am J Respir Crit Care Med. 2020 Jan 15;201(2):148-157. doi: 10.1164/rccm.201903-0656CI.
Zotero 插件